Tetraphase Pharmaceuticals, Inc. approved the election of Dr. L. Patrick Gage and Ms. Nancy Wysenski as class I directors, each to serve for a three year term expiring at the 2017 annual meeting of stockholders at its annual meeting of stockholders held on June 12, 2014.
1st Jan change | Capi. | |
---|---|---|
+42.57% | 739B | |
+32.34% | 598B | |
-5.79% | 353B | |
+17.28% | 318B | |
+3.40% | 285B | |
+16.47% | 240B | |
+9.26% | 210B | |
-5.07% | 206B | |
+6.63% | 164B |